Monopar Therapeutics Inc (MNPR)
Net Income Growth
-116.56%
Quarterly · Period ending:
MNPR Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-116.56%period ending
Latest reported-116.56%period ending
MNPR Quarterly Net Income YoY % (-11.01% → -116.56%)
Year-over-year change
High-resolution chart · PNG
MNPR net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -116.5577% | |
| -48.3082% | |
| 52.3981% | |
| -163.5639% | |
| -43.037% | |
| -59.9397% | |
| -502.3219% | |
| 33.2419% | |
| 22.0311% | |
| 32.5862% | |
| 37.3721% | |
| 18.5824% | |
| 20.3747% | |
| 0.9023% | |
| -8.0484% | |
| 2.3916% | |
| -32.8224% | |
| -30.3979% | |
| -25.9412% | |
| -49.9564% | |
| -43.8757% | |
| -72.7068% | |
| -76.3626% | |
| -122.7497% | |
| -59.5817% | |
| 20.7211% | |
| -35.6021% | |
| -15% | |
| -10.3532% | |
| -57.0776% | |
| -24.6499% | |
| 95.6981% | |
| -38.9171% | |
| -134.8525% | |
| -122.7957% | |
| -7,603.8195% | |
| -75.8929% | |
| -11.0119% |